Crossmark

Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells—first phase I/II human clinical study

Published Online: 2020-03-20

Published Print: 2020-12

Authors

Hertegård, Stellan

Nagubothu, Srinivasa Rau

Malmström, Emma

LeBlanc, Katarina
Funding

Funding for this research was provided by:

The Swedish Research Council (K2011-X-20742-04-6)

Stockholms Läns Landsting (20110152)

Stiftelsen för Strategisk Forskning (IKE-2014-00354)

Laryngfonden (50/14)
License Information

Text and Data Mining valid from 2020-03-20

Version of Record valid from 2020-03-20
More Information

Article History

Received: 14 January 2020

Revised: 24 February 2020

Accepted: 2 March 2020

First Online: 20 March 2020

Ethics approval and consent to participate

: Ethical permissions (DNR 2010/1650 and DNR 2014/51432) were received from the Stockholm regional ethical review committee. Patients provided written informed consent before the procedure. The MSC expansion procedure was accredited by the Swedish National Board of Health and Welfare (952/2009, 6.3.3-8874/2011, 6.1.3-9791/2013, 6.1.3-16411/201).

: The patients gave consent for publication of the data (made unidentifiable).

: The authors declare that they have no competing interests.

Document is current